A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)

NCT01055340 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Oxyntomodulin (OXM)
DRUG: Comparator: Oxyntomodulin (OXM)
DRUG: Comparator: Placebo [ hemaccel-containing saline]

Sponsor

Merck Sharp & Dohme LLC